Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
21:02:58 EDT Thu 18 Apr 2024
Enter Symbol
or Name
USA
CA



Z:DHR - DANAHER CORP - http://www.danaher.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
DHR - Z9.9235.33·236.799.9236.36-3.02-1.34,261.01,002,34838,080232.26  238.44  230.74259.00  182.0919:43:40Mar 2115 min RT 2¢

Recent Trades - Last 10 of 38080
Time ETExPriceChangeVolume
19:43:40Z236.92-2.471
17:33:37Z236.36-3.0325,200
16:20:00Z236.36-3.03418
16:15:04Z236.36-3.031
16:03:29Z236.36-3.03173
16:03:27Z236.36-3.03760
16:03:23Z236.36-3.03102
16:03:22Z236.36-3.03170
16:03:19Z236.36-3.03126
16:03:16Z236.36-3.0335

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2024-03-21 16:15U:DHRNews ReleaseDanaher Schedules First Quarter 2024 Earnings Conference Call
2024-02-27 16:15U:DHRNews ReleaseDanaher to Present at TD Cowen Health Care Conference
2024-02-22 16:15U:DHRNews ReleaseDanaher Commits to Set Science-Based, Net-Zero Greenhouse Gas Emission Reduction Targets
2024-02-21 16:15U:DHRNews ReleaseDanaher Announces Quarterly Dividend
2024-02-05 07:30U:DHRNews ReleaseDanaher Launches Collaboration with Cincinnati Children's Hospital Medical Center Aiming to Improve Patient Safety in Early Drug Development
2024-01-30 06:00U:DHRNews ReleaseDanaher Reports Fourth Quarter and Full Year 2023 Results
2024-01-09 07:30U:DHRNews ReleaseDanaher, Jennifer Doudna, and Innovative Genomics Institute Launch Danaher-IGI Beacon for CRISPR Cures with Aim to Address Hundreds of Diseases Using Gene-editing Platform Solution
2024-01-08 16:15U:DHRNews ReleaseDanaher CEO to Comment on Financial Performance
2024-01-02 17:00U:DHRNews ReleaseDanaher to Present at J.P. Morgan Healthcare Conference
2023-12-21 16:30U:DHRNews ReleaseDanaher Schedules Fourth Quarter 2023 Earnings Conference Call
2023-12-13 16:06U:DHRNews ReleaseCodexis and Aldevron Enter Exclusive Licensing Agreement for Codex ‚ ® HiCap RNA Polymerase
2023-12-06 07:30U:DHRNews ReleaseDanaher Completes Acquisition of Abcam
2023-12-05 16:30U:DHRNews ReleaseDanaher Announces Quarterly Dividend
2023-11-21 16:15U:DHRNews ReleaseDanaher to Present at Evercore ISI HealthCONx Conference
2023-10-31 07:30U:DHRNews ReleaseDanaher appoints Christopher Riley to Executive Vice President for Biotechnology
2023-10-24 06:00U:DHRNews ReleaseDanaher Reports Third Quarter 2023 Results
2023-09-30 08:00U:DHRNews ReleaseDanaher Corporation Completes Separation of Veralto Corporation
2023-09-26 16:15U:DHRNews ReleaseDanaher Schedules Third Quarter 2023 Earnings Conference Call
2023-09-19 07:43U:DHRNews ReleaseDanaher to Provide Cepheid's Tuberculosis Test to the Global Fund at Cost
2023-09-12 16:30U:DHRNews ReleaseDanaher Announces Quarterly Dividend